Citation Impact
Citing Papers
Role of UEV-1, an Inactive Variant of the E2 UbiquitinConjugating Enzymes, in In Vitro Differentiation and Cell Cycle Behavior of HT-29-M6 Intestinal Mucosecretory Cells
1998 StandoutNobel
Risk Factors for Venous Thromboembolism
2003 Standout
Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota
2012 StandoutScience
Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130
2002 StandoutNobel
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
2007 StandoutScience
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
2004 Standout
Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study.
1994
Macrosphelide B Suppressed Metastasis through Inhibition of Adhesion of sLex/E-Selectin Molecules
2002 StandoutNobel
Inflammation and cancer
2002 StandoutNature
Minimal Sulfated Carbohydrates for Recognition by L-selectin and the MECA-79 Antibody
2000 StandoutNobel
Macrosphelides C and D, Novel Inhibitors of Cell Adhesion.
1997 StandoutNobel
Inositol phosphates and cell signalling
1989 StandoutNature
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Alteration in mucin gene expression and biological properties of HT29 colon cancer cell subpopulations
1996
Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis
1989
Selectins.
1993
A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials
1999
Changes in α(1–2)-Fucosyltransferase Activity in the Murine Endometrial Epithelium during the Estrous Cycle, Early Pregnancy, and after Ovariectomy and Hormone Replacement1
1994
Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis
2005 Standout
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old
2006 Standout
Increased levels of α6 integrins are associated with the metastatic phenotype of human breast cancer cells
1999
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
Platelet Activation and Atherothrombosis
2007 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Voltage-activated potassium, but not calcium currents in cultured bovine aortic endothelial cells
1987
Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms
2009
Macrosphelide, a Novel Inhibitor of Cell-cell Adhesion Molecule. II. Physicochemical Properties and Structural Elucidation.
1996 StandoutNobel
Immunity, Inflammation, and Cancer
2010 Standout
Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer
2002 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Selectins as potential targets of therapeutic intervention in inflammatory diseases
1994
Platelets in inflammation and atherogenesis
2005 Standout
Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling
2007 StandoutNobel
Inflammation and cancer: back to Virchow?
2001 Standout
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Atherosclerosis — An Inflammatory Disease
1999 Standout
Tobacco Smoke Carcinogens and Lung Cancer
1999 Standout
Mechanisms of Hypercoagulation in Malignancy and during Chemotherapy
1998
Mucin Granule Intraluminal Organization in Living Mucous/Goblet Cells
2005 StandoutNobel
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Mechanisms of Bone Metastasis
2004 Standout
The selectins and their ligands
1994 StandoutNobel
Cancer-related inflammation
2008 StandoutNature
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions
2006
Implantation and the placenta: key pieces of the development puzzle
1994 StandoutScience
Anin vitro invasion model for human renal cell carcinoma cell lines mimicking their metastatic abilities
1996
Alternative activation of macrophages
2003 Standout
Macrosphelide, a Novel Inhibitor of Cell-cell Adhesion Molecule. I. Taxonomy, Fermentation, Isolation and Biological Activities.
1995 StandoutNobel
Differential roles of IL-1 and TNF-α on graft-versus-host disease and graft versus leukemia
1999
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
Anti-adhesive therapeutics: A new class of anti-inflammatory agents
1994
Relative and Absolute Stereochemistries and Total Synthesis of (+)-Macrosphelides A and B, Potent, Orally Bioavailable Inhibitors of Cell−Cell Adhesion
1997 StandoutNobel
ExBox: A Polycyclic Aromatic Hydrocarbon Scavenger
2012 StandoutNobel
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
Tumor Cell Interactions With the Microvasculature
2001
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Inhibition of colon carcinoma cell lung colony formation by a soluble form of E-selectin.
1997
Adhesion of Activated Platelets to Endothelial Cells: Evidence for a GPIIbIIIa-dependent Bridging Mechanism and Novel Roles for Endothelial Intercellular Adhesion Molecule 1 (ICAM-1), αvβ3 Integrin, and GPIbα
1998
n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
2013 Standout
Absolute stereochemistries and total synthesis of (+)/(−)-macrosphelides, potent, orally bioavailable inhibitors of cell–cell adhesion
2005 StandoutNobel
Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma
2002
Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air.
2002
The von Hippel-Lindau Tumor Suppressor Gene Inhibits Hepatocyte Growth Factor/Scatter Factor-Induced Invasion and Branching Morphogenesis in Renal Carcinoma Cells
1999 StandoutNobel
Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium.
1993
Efficient Total Synthesis of Novel Bioactive Microbial Metabolites
2008 StandoutNobel
Polymerized Liposome Assemblies: Bifunctional Macromolecular Selectin Inhibitors Mimicking Physiological Selectin Ligands
2001 StandoutNobel
Integrin VLA-2 (alpha2beta1) function in postextravasation movement of human rhabdomyosarcoma RD cells in the liver.
1996
Evidence that agonists stimulate bivalent-cation influx into human endothelial cells
1988
Flow-mediated endothelial mechanotransduction
1995 Standout
Works of D Lauri being referenced
Appropriate use of antiplatelets: is prescription in daily practice influenced by the global cardiovascular risk?
2005
Tumor Cell Adhesion to Endothelial Cells: Endothelial Leukocyte Adhesion Molecule-1 as an Inducible Adhesive Receptor Specific for Colon Carcinoma Cells
1991
Interleukin-1 increases tumor cell adhesion to endothelial cells through an RGD dependent mechanism: in vitro and in vivo studies
1990
Interleukin 1-induced cancer cell/endothelial cell adhesion in vitro and its relationship to metastasis in vivo: role of vessel wall 13-HODE synthesis and integrin expression
1993
Chemotherapy enhances endothelial cell reactivity to platelets
1990
Hemoglobin adducts of benzo[a]pyrene diolepoxide in newspaper vendors: association with traffic exhaust
1996
Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients' risk level
2006
Endothelial leukocyte adhesion molecule-1-dependent adhesion of colon carcinoma cells to vascular endothelium is inhibited by an antibody to Lewis fucosylated type I carbohydrate chain.
1992
Role of beta 1 integrins in tumor cell adhesion to cultured human endothelial cells.
1991
Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression.
1991
Differential effects of interleukin-1 and formylmethionylleucylphenylalanine on chemotaxis and human endothelium adhesivity for A549 tumor cells.
1989
Chemotactic activity of endothelial cell-derived interleukin 1 for human tumor cells.
1988
Alkyl-ether phosphoglycerides influence calcium fluxes into human endothelial cells.
1985
Amplification of primary response of human platelets to platelet-activating factor: aspirin-sensitive and aspirin-insensitive pathways.
1985
How general practitioners perceive and grade the cardiovascular risk of their patients
2004